Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Contrave: Additional Phase IIb data

Additional data from a double-blind, placebo-controlled Phase IIb trial (NB201) in 419 obese

Read the full 134 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE